Chylous Effusion Interpreter
Chylous Effusion Interpreter
A milky effusion is either chyle from a disrupted lymphatic or a long-standing effusion that has accumulated cholesterol, and the two have entirely different causes and management. Triglyceride and cholesterol separate them in most cases — but a quarter of pseudochylous effusions meet the chylous triglyceride criterion, and one in seven true chylothoraces fails it.
Is this milky fluid chyle, or cholesterol?
Triglyceride + cholesterol → chylous or pseudochylousA 58-year-old develops a high-volume, milky right pleural drain output on the third day after an oesophagectomy, having restarted enteral feeding. The fluid triglyceride is 2.4 mmol/L and the fluid cholesterol is 1.7 mmol/L. No lipoprotein electrophoresis or crystal examination has been done.
Three lipid findings, in the order they should be asked
Triglyceride above 110 mg/dL (1.24 mmol/L) — chylous in essentially every case in the original series. Below 50 mg/dL (0.56 mmol/L) — chylothorax virtually excluded. Between the two — send the electrophoresis.
Cholesterol above 200 mg/dL (5.17 mmol/L), a cholesterol-to-triglyceride ratio above 1, or cholesterol crystals — pseudochylous. The ratio is a mass ratio, so in mmol/L the comparison becomes cholesterol against 2.29 × triglyceride.
The overlap is real in both directions: 25% of pseudochylous effusions have triglycerides above 110 mg/dL, and 14% of confirmed chylothoraces have triglycerides below it.
Worked example
A 58-year-old develops a high-volume, milky right pleural drain output on the third day after an oesophagectomy, having restarted enteral feeding. The fluid triglyceride is 2.4 mmol/L and the fluid cholesterol is 1.7 mmol/L. No lipoprotein electrophoresis or crystal examination has been done.
No chylomicron result and no crystal result, so the first two rules do not apply
Cholesterol 1.7 mmol/L is 65.7 mg/dL — nowhere near the 200 mg/dL (5.17 mmol/L) that marks a cholesterol-rich fluid, and close to the mean of about 66 mg/dL reported in confirmed chylothorax. The pseudochylous rule does not fire
Triglyceride 2.4 mmol/L is 212 mg/dL, comfortably above the 110 mg/dL (1.24 mmol/L) chylous threshold
Cholesterol-to-triglyceride mass ratio = 65.7 ÷ 212 = 0.31, well under 1 — a chylous rather than a pseudochylous pattern
Setting fits: oesophagectomy is one of the commonest causes of a traumatic chylothorax, and the output rose when enteral feeding restarted, which is what chyle does
Action: drainage, a low-fat diet with medium-chain triglycerides or parenteral nutrition, monitoring of protein and fat-soluble vitamins, and duct imaging with ligation or embolisation if the output does not fall
Change one entry and the page changes with it. Raise the cholesterol to 8.0 mmol/L (309 mg/dL), leaving the triglyceride at 2.4 mmol/L (212 mg/dL), and the same fluid reads as pseudochylous — because the mass ratio becomes 1.46, above 1. That is the quarter of pseudochylous effusions that meet the chylous triglyceride criterion
Chylous against pseudochylous
| Feature | Chylous effusion | Pseudochylous effusion |
|---|---|---|
| Mechanism | Leak of chyle from a disrupted thoracic duct or its tributaries | Cholesterol accumulating in a long-standing effusion with a thickened pleura |
| Duration | Appears over hours to days | Classically present for years |
| Triglyceride | Above 110 mg/dL (1.24 mmol/L) — but 14% are below it | Usually low — but 25% are above 110 mg/dL |
| Cholesterol | Mean about 66 mg/dL | Median 332 mg/dL; 74.3% above 200 mg/dL |
| Cholesterol : triglyceride (mass) | Below 1 | Above 1 in 97.4% — the single most sensitive finding |
| Cholesterol crystals | Absent | Present in 89.7% |
| Chylomicrons | Present — the criterion standard | Absent |
| Commonest causes | Trauma and thoracic surgery; lymphoma; other malignancy; lymphangioleiomyomatosis; cirrhosis | Tuberculosis 42.5% and rheumatoid arthritis 38.0% — 88.5% between them |
| What it needs | Duct imaging, low-fat or MCT diet, ligation or embolisation | Treatment of the underlying disease; decortication for a trapped lung |
The same thresholds in both units
| Threshold | mg/dL | mmol/L | Conversion used |
|---|---|---|---|
| Triglyceride — chylous above | 110 | About 1.24 | × 0.011294. The exact equivalent is 1.2423, so a rounded 1.24 mmol/L is below the threshold — see the caption, and the triglyceride converter |
| Triglyceride — chylothorax virtually excluded below | 50 | About 0.56 | × 0.011294. The exact equivalent is 0.5647 |
| Cholesterol — cholesterol-rich above | 200 | About 5.17 | × 0.0258632. The exact equivalent is 5.1726 — see the cholesterol converter |
| Cholesterol : triglyceride ratio | Above 1 | Not 1. Above 2.29 × triglyceride | The published ratio is a mass ratio and does not survive conversion. 88.5425 ÷ 38.6649 = 2.290 |
Two milky fluids, two different diseases, and an overlap in both directions
A turbid or milky pleural effusion has three common explanations and only one of them is a lymphatic leak. Chyle is intestinal lymph, rich in chylomicron triglyceride, escaping from the thoracic duct or one of its tributaries. A pseudochylous or cholesterol effusion is something else entirely: a long-standing effusion, classically present for years inside a thickened fibrous pleura, in which cholesterol released by degenerating cells has accumulated to concentrations several times those in serum. And an empyema is turbid because of cells and debris rather than lipid, which is the easiest of the three to exclude — spin the sample, and pus clears with a cellular deposit while chyle and pseudochyle stay turbid.
The lipid measurements separate the first two in most cases. Staats and colleagues established the thresholds that are still used: every effusion with a triglyceride above 110 mg/dL in their series proved chylous, and a triglyceride below 50 mg/dL virtually excluded a chylothorax, leaving a band between the two in which lipoprotein electrophoresis for chylomicrons — the criterion standard — is the answer. Cholesterol points the other way: a mean of about 66 mg/dL in confirmed chylothorax against a median of 332 mg/dL in pseudochylothorax, where three-quarters of cases exceed 200 mg/dL and nine in ten have cholesterol crystals on microscopy.
What the tidy version of that leaves out is that the overlap runs in both directions and is not small. Fourteen per cent of seventy-four confirmed chylothoraces in one Mayo Clinic review had triglycerides below 110 mg/dL, two of them below 50 — and those low values clustered in fasting and postoperative patients, because chyle carries dietary fat and a patient absorbing none produces chyle with little triglyceride in it. Going the other way, a quarter of the pseudochylothoraces in a systematic review had triglycerides above 110 mg/dL and so met the chylous criterion outright. The findings that rescue those cases are the cholesterol-to-triglyceride ratio, above one in 97.4 per cent of pseudochylous effusions, and cholesterol crystals, present in 89.7 per cent.
One arithmetical trap deserves stating on its own, because it is invisible. The cholesterol-to-triglyceride ratio of one is a mass ratio, derived from results in mg/dL, and it does not survive conversion to molar units. Cholesterol has a molar mass of about 387 and the triglyceride assay is standardised against a molecule of about 885, so converting both to mmol/L inflates cholesterol relative to triglyceride by a factor of 2.29. A ratio computed from mmol/L results and compared against one will classify almost every effusion as pseudochylous. In molar units the comparison has to be cholesterol against 2.29 times the triglyceride, which is what this page does.
Frequently asked questions
What triglyceride level diagnoses a chylous effusion?
Above 110 mg/dL (1.24 mmol/L) in the fluid. In Staats' original series every effusion above that figure proved chylous, and below 50 mg/dL (0.56 mmol/L) chylothorax was virtually excluded. Between the two the triglyceride does not decide and lipoprotein electrophoresis for chylomicrons is the test to send. Two qualifications: 14% of confirmed chylothoraces in a later review had triglycerides below 110 mg/dL, and a quarter of pseudochylous effusions have triglycerides above it.
What is a pseudochylous effusion and how is it different?
It is a long-standing effusion — classically present for years inside a thickened fibrous pleura — in which cholesterol from degenerating cells has accumulated, rather than a lymphatic leak. The fluid cholesterol is the discriminator: a median of 332 mg/dL against a mean of about 66 mg/dL in chylothorax, with 74.3% of cases above 200 mg/dL and cholesterol crystals present in 89.7%. The causes are different too — tuberculosis and rheumatoid arthritis account for 88.5% between them, so the workup is mycobacterial testing and rheumatoid serology rather than a duct study.
The patient is nil by mouth and the triglyceride is low. Does that exclude a chylothorax?
No. Chyle carries dietary fat, so a patient who is fasting, nil by mouth after surgery or on parenteral nutrition produces chyle with much less triglyceride in it. In a review of 74 confirmed chylothoraces, 14% had triglycerides below 110 mg/dL and two cases were below 50 mg/dL, and those low values occurred principally in fasting and postoperative patients. Send lipoprotein electrophoresis for chylomicrons, or give a fat-containing enteral feed and repeat the triglyceride — it rises sharply if the drainage is chyle.
Can I calculate the cholesterol-to-triglyceride ratio from results in mmol/L?
Not against a threshold of 1. The published ratio is a mass ratio derived from mg/dL results, and converting both analytes to molar units inflates cholesterol relative to triglyceride by a factor of 2.29 — because cholesterol's molar mass is about 387 and the triglyceride assay is standardised against a molecule of about 885. A ratio computed from mmol/L and compared against 1 will call nearly every effusion pseudochylous. Either convert both results to mg/dL with the cholesterol converter and the triglyceride converter, or compare cholesterol against 2.29 times the triglyceride, which is what this page does internally.
The fluid is milky but the triglyceride and cholesterol are both unremarkable. What else could it be?
Most often an empyema, where the turbidity comes from cells and debris rather than lipid. The quickest test is centrifugation: pus clears leaving a cellular deposit, while chyle and pseudochyle stay turbid. Send cell count, differential, Gram stain and culture, and read the pH with the pleural fluid pH interpreter, which decides whether the collection needs draining. A rarer possibility in an inpatient is lipid-containing parenteral nutrition delivered into the pleural space by a misplaced central line, which the timing and the line position will reveal.
Does a chylous effusion need to be classified as a transudate or an exudate as well?
Yes — the classification and the lipid analysis answer different questions and both are worth having. Most chylothoraces are exudates, but cirrhotic and some other chylous effusions behave as transudates, and the distinction still directs the workup. Run the Light's criteria calculator on the same sample. In practice the appearance of the fluid should prompt the lipid tests and the standard protein and LDH measurements at the same time, rather than in sequence.
Related calculators
References
- Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc. 1980;55(11):700–704.
- Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc. 2009;84(2):129–133.
- Lama A, Ferreiro L, Toubes ME, et al. Characteristics of patients with pseudochylothorax — a systematic review. J Thorac Dis. 2016;8(8):2093–2101.
- Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society Guideline for pleural disease. Thorax. 2023;78(Suppl 3):s1–s42.
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.